Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01843374
Brief Title: Randomized, Double-blind Study Comparing Tremelimumab to Placebo in Subjects With Unresectable Malignant Mesothelioma (Tremelimumab)

First Submitted : April 22, 2013
First Submitted that Met QC Criteria : April 25, 2013
First Posted : April 30, 2013 (Estimate)

Results First Submitted : April 10, 2017
Results First Submitted that Met QC Criteria : August 15, 2017
Results First Posted : August 17, 2017

Certification/Extension First Submitted : January 24, 2017
Certification/Extension First Submitted that Met QC Criteria : January 24, 2017
Certification/Extension First Posted : January 25, 2017 (Estimate)

Last Update Submitted that Met QC Criteria : March 18, 2019
Last Update Posted : March 27, 2019